Web Analytics

3 Latest Announced Rounds

  • $8,000,000
    Seed

    3 Investors

    Software Development
    Jan 7th, 2026
  • $5,400,000
    Seed

    1 Investors

    Mobile Gaming Apps
    Jan 7th, 2026
  • $10,500,000
    Seed

    2 Investors

    Technology, Information and Media
    Jan 7th, 2026
$267.50M Raised in 10 Funding Rounds in the past 7 Days - View All

Funding Round Profile

AI Proteins

start up
United States - Boston, Massachusetts
  • 21/11/2025
  • Series A
  • $41,500,000

Boston-based AI Proteins is a biotech company on a mission to re-imagine protein therapeutics with a novel approach for designing entirely new proteins. Using AI-enabled design and a high-throughput drug discovery platform, AI Proteins creates de novo miniproteins optimized for a variety of therapeutic applications. Partnered with leading biopharmaceutical companies, AI Proteins continues to pursue collaborations across a wide variety of therapeutic areas in addition to advancing its internal pipeline. The AI Proteins platform can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies.


Related People

Chris BahlFounder

Chris Bahl United States - Boston, Massachusetts

N/A